This dual action not only aids in diabetes management but also plays a pivotal role in reducing cardiovascular risk factors such as high blood pressure and unhealthy lipid levels
These successes are even more pronounced in those treated with tirzepatide, with nearly 60% of patients losing 20% of their weight and nearly 40% losing even more than 25% of their initial weight (Figure 6B)
Incretin pharmacology: a review of the incretin effect and current incretin-based therapies
Researchers in the 1980s made a key discovery
Jonathan Bonnet, a board-certified physician in family, sports, obesity, and Lifestyle Medicine, the session explores prescribing strategies, expected outcomes, patient counseling, and real-world considerations that family physicians commonly encounter